Despite a considerable amount of research attributed to the development of
an implantable glucose sensor, to date there is no clinically applicable co
ncept for continuous glucose monitoring. Investigations to validate the sub
cutaneous tissue for continuous glucose sensing mostly comprised short-term
implantations of glucose sensors. Most implanted glucose sensors showed a
significant drift in sensitivity over the implantation period. This bioinst
ability was not to be expected from the in vitro performance of the sensors
. In this paper, the influence of possible failure mechanisms on the poor i
n vivo performance of subcutaneously implanted glucose sensors is reviewed.
(C) 1999 Elsevier Science B.V. All rights reserved.